-transparent.png){kind=logo}
We investigated whether captopril, an angiotensin-converting-enzyme inhibitor, would reduce proteinuria in patients with advanced diabetic nephropathy. Captopril (37.5 mg given in divided doses three times daily) was administered to 10 azotemic diabetics with heavy proteinuria. Urinary protein decreased promptly within two weeks (from 10.6 +/- 2.2 to 6.1 +/- 1.4 g per day [mean +/- S.E.M.]; P less than 0.01). The decrease in proteinuria did not coincide with a fall in systemic blood pressure or in the blood glucose concentration. Serum creatinine and potassium values did not change in any of the patients except one. We suggest that captopril caused a decrease in intrarenal hypertension, which contributed to the reduction of urinary protein excretion. The therapeutic value of this intervention remains to be established.
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
September 1992,
Yonsei medical journal,
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
August 1986,
The New England journal of medicine,
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
January 1991,
The Journal of international medical research,
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
September 1990,
Nihon Jinzo Gakkai shi,
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
January 1988,
Therapia Hungarica (English edition),
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
April 1987,
Orvosi hetilap,
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
September 1985,
Orvosi hetilap,
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
January 1988,
Japanese journal of pharmacology,
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
January 1986,
Clinical and experimental hypertension. Part A, Theory and practice,
Y Taguma, and
Y Kitamoto, and
G Futaki, and
H Ueda, and
H Monma, and
M Ishizaki, and
H Takahashi, and
H Sekino, and
Y Sasaki
March 1995,
Vnitrni lekarstvi,
